NCT07769034

Brief Summary

This randomized controlled trial aims to investigate whether the timing of transcutaneous auricular vagus nerve stimulation (taVNS) relative to exercise influences clinical and autonomic outcomes in individuals with chronic neck pain. Participants will be randomly allocated to one of three groups: taVNS applied before exercise, taVNS applied after exercise, or exercise alone. All groups will receive a standardized exercise program designed for chronic neck pain. The intervention will be conducted over a 6- to 8-week period. The effects of the interventions will be evaluated using pain intensity, neck-related disability, sleep quality, heart rate variability, and exercise adherence. The study will determine whether applying taVNS before or after exercise provides additional benefits compared with exercise alone and whether the timing of stimulation influences treatment outcomes.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
81

participants targeted

Target at P50-P75 for not_applicable

Timeline
12mo left

Started Sep 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 12, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 17, 2026

Completed
28 days until next milestone

Study Start

First participant enrolled

September 14, 2026

Expected
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2027

3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2027

Last Updated

August 17, 2026

Status Verified

August 1, 2026

Enrollment Period

10 months

First QC Date

August 12, 2026

Last Update Submit

August 12, 2026

Conditions

Keywords

CHRONIC PAINVAGAL NERVE STIMULATIONEXERCISE

Outcome Measures

Primary Outcomes (3)

  • Change in Pain Intensity - Numeric Pain Rating Scale

    Pain intensity will be assessed using the Numeric Pain Rating Scale (NPRS). Participants will rate their neck pain on an 11-point scale ranging from 0 to 10, where 0 indicates "no pain" and 10 indicates "worst imaginable pain." Higher scores indicate greater pain intensity. Change from baseline will be compared between groups.

    Baseline and immediately after completion of the 6 week interventions

  • Change in Neck-Related Disability - Neck Disability Index

    Neck-related disability will be assessed using the Neck Disability Index (NDI). The questionnaire consists of 10 sections scored from 0 to 5, producing a total score ranging from 0 to 50. Higher scores indicate greater neck-related disability.

    Baseline and immediately after completion of the 6 weeks interventions.

  • Change in Sleep Quality - Pittsburgh Sleep Quality Index

    Sleep quality will be assessed using the Pittsburgh Sleep Quality Index (PSQI). The PSQI evaluates seven components of sleep and provides a global score ranging from 0 to 21. Higher scores indicate poorer sleep quality.

    Baseline and immediately after completion of the 6 weeks intervention.

Secondary Outcomes (2)

  • Exercise Adherence

    Throughout the 6-8-week intervention period.

  • Change in Heart Rate Variability - RMSSD

    Baseline and immediately after completion of the 6 weeks intervention.

Study Arms (3)

taVNS Before Exercise

EXPERIMENTAL

Participants will receive transcutaneous auricular vagus nerve stimulation before performing the standardized exercise program.

Device: Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)Other: Exercise Program

taVNS After Exercise

EXPERIMENTAL

Participants will first perform the standardized exercise program and will subsequently receive transcutaneous auricular vagus nerve stimulation.

Device: Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)Other: Exercise Program

Exercise only

ACTIVE COMPARATOR

Participants will receive the standardized exercise program without transcutaneous auricular vagus nerve stimulation.

Other: Exercise Program

Interventions

Transcutaneous auricular vagus nerve stimulation will be delivered non-invasively through an auricular stimulation device targeting the auricular branch of the vagus nerve. Stimulation will be administered under researcher supervision using standardized stimulation parameters according to the device instructions and study protocol.

taVNS After ExercisetaVNS Before Exercise

Participants will perform a standardized exercise program for chronic neck pain including postural correction, deep cervical flexor activation, cervical mobility, scapular stabilization, and stretching exercises. Exercises will be performed under researcher supervision during the intervention period.

Exercise onlytaVNS After ExercisetaVNS Before Exercise

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of chronic neck pain confirmed by a physical medicine and rehabilitation physician.
  • Age between 18 and 65 years.
  • Neck pain persisting or recurring for at least 3 months.
  • Ability to participate in the exercise program included in the study protocol.
  • No contraindication to transcutaneous auricular vagus nerve stimulation.
  • Willingness to provide written informed consent.
  • Willingness to participate regularly in the planned exercise and assessment sessions.

You may not qualify if:

  • Cervical radiculopathy or specific neurological findings.
  • Previous cervical spine surgery.
  • Serious cardiovascular disease.
  • Serious neurological or systemic disease.
  • Pregnancy.
  • Orthopedic or musculoskeletal conditions preventing participation in exercise.
  • Cognitive or communication problems that prevent completion of the assessment instruments.
  • Inability or unwillingness to comply with the study protocol or attend scheduled sessions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kutahya Health Sciences University Physical Therapy and Rehabilitation Research Center

Kütahya, Türkiye, 43100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Chronic PainMotor Activity

Interventions

Resistance Training

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsBehavior

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPhysical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Central Study Contacts

Batuhan YUKSEL, Msc.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD

Study Record Dates

First Submitted

August 12, 2026

First Posted

August 17, 2026

Study Start (Estimated)

September 14, 2026

Primary Completion (Estimated)

June 30, 2027

Study Completion (Estimated)

September 15, 2027

Last Updated

August 17, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

Locations